rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-8-14
|
pubmed:abstractText |
It has been previously observed that patients with head and neck squamous cell carcinoma or with laryngeal leucoplakia present a significant reduction in plasma folate levels. The current Phase IIA pilot study assessed the effectiveness of folic acid as a chemopreventive agent in patients affected by glottic laryngeal leucoplakia.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
328-36
|
pubmed:meshHeading |
pubmed-meshheading:16770770-Adult,
pubmed-meshheading:16770770-Aged,
pubmed-meshheading:16770770-Female,
pubmed-meshheading:16770770-Folic Acid,
pubmed-meshheading:16770770-Humans,
pubmed-meshheading:16770770-Laryngeal Neoplasms,
pubmed-meshheading:16770770-Laryngoscopy,
pubmed-meshheading:16770770-Leukoplakia,
pubmed-meshheading:16770770-Male,
pubmed-meshheading:16770770-Middle Aged,
pubmed-meshheading:16770770-Pilot Projects,
pubmed-meshheading:16770770-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Pilot phase IIA study for evaluation of the efficacy of folic acid in the treatment of laryngeal leucoplakia.
|
pubmed:affiliation |
Institute of Otolaryngology, Universita Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome, Italy. almgio@yahoo.it
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|